Explore evidence

75 %Using a cut-off value of 0.45, the sensitivity of squamous cell carcinoma antigen was 75%.

Nigeriacancer du col de l'utéruspublished 2025European journal of medical researchPubMeddocument of 8 observations

30.1 per_100_women_yearsThe mortality rate for cervical cancer was 30.1 per 100 women-years.

Nigeriacancer du col de l'utérusobserved 2015–2021published 2025International healthPubMeddocument of 2 observations

12 %Post-intervention, knowledge of cervical cancer symptoms increased to 12.0% in the control group.

Nigeriacancer du col de l'utéruspublished 2022West African journal of medicinePubMeddocument of 12 observations

0.3 %One respondent (0.3%) had been screened with visual inspection with acetic acid.

Nigeriacancer du col de l'utéruspublished 2021JCO global oncologyPubMeddocument of 7 observations

7,093 deaths_per_yearEach year, an average of 7093 women in Nigeria die from cervical cancer.

Nigeriacancer du col de l'utéruspublished 2025JMIR cancerPubMeddocument of 8 observations

Cervical cancer is the second most common cancer among women worldwide.

Nigeriacancer du col de l'utéruspublished 2021Journal of preventive medicine and hygienePubMeddocument of 11 observations

96.2 %Among 400 female students in tertiary institutions in Imo State, 385 (96.2%) knew that Human Papillomavirus (HPV) is the causative agent of cervical cancer.

Nigeriacancer du col de l'utérus · human papillomavirus (HPV)published 2021Journal of community healthPubMeddocument of 9 observations

49 womenAmong the women screened, 49 (<1%) received both VIA and HPV DNA testing at the same time.

Nigeriacancer du col de l'utérusobserved 2021published 2023BMC public healthPubMeddocument of 12 observations

3.6 aORIn the presence of high-risk HPV, community state type IV (CST-IV) was associated with high-grade squamous intraepithelial lesion or invasive cervical cancer with an adjusted odds ratio of 3.6.

Nigeriacancer du col de l'utérus · high-grade squamous intraepithelial lesion · high-risk human papillomavirusobserved 2020–2022published 2023BMC cancerPubMeddocument of 14 observations

23.3 %23.3% of rural women in North Central Nigeria cited lack of knowledge about the test as a barrier to cervical cancer screening.

Nigeriacancer du col de l'utéruspublished 2026Rural and remote healthPubMeddocument of 21 observations

2 %About 2% of women screened for cervical cancer at Jos University Teaching Hospital in Nigeria were women living with HIV.

Nigeriacancer du col de l'utérus · VIH/sidapublished 2024Cancer causes & control : CCCPubMeddocument of 5 observations

7 %VIA positivity was 7% among women living with HIV in Nigeria.

Nigeriacancer du col de l'utérusAfrica CDCdocument of 52 observations

10.1 %Post-intervention, knowledge of cervical cancer symptoms increased from 10.1% to 66.5% in the intervention group.

Nigeriacancer du col de l'utéruspublished 2022West African journal of medicinePubMeddocument of 12 observations

84.5 %The primary case finder screening negative predictive value was 84.5% using gynaecologist review as confirmatory test.

Nigeriacancer du col de l'utérusobserved October 2020 to July 2021published 2023Reproductive healthPubMeddocument of 9 observations

90.3 %90.3% of women in Taraba, North-East Nigeria had appropriate knowledge about the prevention of cervical cancer.

Nigeriacancer du col de l'utéruspublished 2019Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 6 observations

66.05 %Knowledge of HPV and cervical cancer among junior secondary school aged girls had a mean score of 66.05%.

Nigeriacancer du col de l'utérus · infection à HPVpublished 2022BMC public healthPubMeddocument of 6 observations

604,000 casesGlobally, cervical cancer accounts for 604,000 new cases annually.

Nigeriacancer du col de l'utéruspublished 2025European journal of medical researchPubMeddocument of 8 observations

1.1 %Four respondents (1.1%) had taken the human papillomavirus vaccine before.

Nigeriacancer du col de l'utéruspublished 2021JCO global oncologyPubMeddocument of 7 observations

70.3 %70.3% of HIV-positive women had high-grade squamous intraepithelial lesion or invasive cervical cancer (HSIL/ICC).

Nigeriacancer du col de l'utérus · high-grade squamous intraepithelial lesion · VIH/sidaobserved 2020–2022published 2023BMC cancerPubMeddocument of 14 observations

79.2 %79.2% of the respondents were willing to vaccinate their adolescent daughters against HPV.

Nigeriacancer du col de l'utéruspublished 2020The Pan African medical journalPubMeddocument of 5 observations

51 %The high-risk HPV detection rate was 51% among 101 cervical carcinoma cases.

Nigeriacancer du col de l'utérusobserved 2012–2016published 2024The Pan African medical journalPubMeddocument of 5 observations

6.13 nmol/lThe mean serum malondialdehyde level was 6.13 ± 4.1 nmol/l among women with histologically confirmed cervical cancer.

Nigeriacancer du col de l'utéruspublished 2024West African journal of medicinePubMeddocument of 4 observations

15 %Cervical cancer screening rates were below 15% in Nigeria.

Nigeriacancer du col de l'utéruspublished 2026BMC public healthPubMeddocument of 3 observations

52.8 %52.8% of the 231 women received information about cervical cancer screening from friends.

Nigeriacancer du col de l'utéruspublished 2021Cancer treatment and research communicationsPubMeddocument of 11 observations

36 %36% of rural women in North Central Nigeria expressed willingness to undergo cervical cancer screening.

Nigeriacancer du col de l'utéruspublished 2026Rural and remote healthPubMeddocument of 21 observations